EHE 0.42% $2.38 estia health limited

Mixed results. The revenue and EBITDA growth seems to be slowing...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7 Posts.
    Mixed results. The revenue and EBITDA growth seems to be slowing down. However the amount of debt relative to EBITDA is significantly improved. The issue is the change to funding from the government surrounding these homes. However my initial reason for buying this stock was to gain exposure to the ageing Australian population. And as you can see in the image below that's only going to benefit EHE. But short term there may be some growing pains. But DYOR.
 
watchlist Created with Sketch. Add EHE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.